Barr Pharmaceuticals

From WikiMD's WELLNESSPEDIA

Barr Pharmaceuticals was a global specialty pharmaceutical company that developed, manufactured, and marketed both generic and proprietary pharmaceuticals. The company was founded in 1970 and was headquartered in Woodcliff Lake, New Jersey. Barr Pharmaceuticals was known for its significant role in the development and marketing of generic drugs.

History[edit]

Barr Pharmaceuticals was established in 1970 by Edwin A. Cohen. The company initially focused on the development and marketing of generic drugs, which are bioequivalent to brand-name drugs but are typically sold at lower prices. Over the years, Barr Pharmaceuticals expanded its product line to include proprietary pharmaceuticals.

In 2006, Barr Pharmaceuticals acquired Pliva, a Croatian pharmaceutical company, which significantly expanded its presence in the European market. This acquisition made Barr Pharmaceuticals one of the largest generic drug manufacturers in the world.

Products[edit]

Barr Pharmaceuticals produced a wide range of pharmaceutical products, including:

The company was particularly well-known for its oral contraceptives, which were a significant part of its product portfolio.

Acquisition by Teva[edit]

In 2008, Barr Pharmaceuticals was acquired by Teva Pharmaceutical Industries, an Israeli multinational pharmaceutical company. The acquisition was valued at approximately $7.5 billion and was completed in December 2008. This acquisition further solidified Teva's position as a leading global generic pharmaceutical company.

Legacy[edit]

The acquisition of Barr Pharmaceuticals by Teva Pharmaceutical Industries allowed Teva to expand its product offerings and market reach. Barr Pharmaceuticals' legacy continues through Teva's extensive portfolio of generic and proprietary drugs.

See also[edit]

References[edit]


External links[edit]

Wikimedia Commons logo
Wikimedia Commons has media related to

Barr_Pharmaceuticals

.
This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Barr_Pharmaceuticals&oldid=6614337"